A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT06116565 · COMPLETED
Trial details
- NCT number
- NCT06116565
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-21
- Primary completion
- 2025-11-26
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.